Related references
Note: Only part of the references are listed.Spray-Dried Formulation of Epicertin, a Recombinant Cholera Toxin B Subunit Variant That Induces Mucosal Healing
Micaela A. Reeves et al.
PHARMACEUTICS (2021)
A modified cholera toxin B subunit containing an ER retention motif enhances colon epithelial repair via an unfolded protein response
Joshua M. Royal et al.
FASEB JOURNAL (2019)
Repeated Oral Administration of a KDEL-Tagged Recombinant Cholera Toxin B Subunit Effectively Mitigates DSS Colitis despite a Robust Immunogenic Response
Joshua M. Royal et al.
TOXINS (2019)
Mechanisms of Disease: Inflammatory Bowel Diseases
Guilherme Piovezani Ramos et al.
MAYO CLINIC PROCEEDINGS (2019)
Reference values for selected hematological, biochemical and physiological parameters of Sprague-Dawley rats at the Animal House, Faculty of Medicine, University of Colombo, Sri Lanka
Shehani L. Delwatta et al.
ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2018)
Oral administration of a recombinant cholera toxin B subunit promotes mucosal healing in the colon
K. J. Baldauf et al.
MUCOSAL IMMUNOLOGY (2017)
Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa
Joshua M. Royal et al.
TOXINS (2017)
Animal models to study acute and chronic intestinal inflammation in mammals
Janelle A. Jiminez et al.
GUT PATHOGENS (2015)
Cholera Toxin B: One Subunit with Many Pharmaceutical Applications
Keegan J. Baldauf et al.
TOXINS (2015)
Experimental Models of Inflammatory Bowel Diseases
Patricia Kiesler et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Rapid and Scalable Plant-based Production of a Cholera Toxin B Subunit Variant to Aid in Mass Vaccination against Cholera Outbreaks
Krystal Teasley Hamorsky et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Central role of the gut epithelial barrier in the pathogenes of chronic intestinal inflammation: lessons learned from animal models and human genetics
Luca Pastorelli et al.
FRONTIERS IN IMMUNOLOGY (2013)
Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks
Martina Perse et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Clinical trial: the safety and short-term efficacy of recombinant cholera toxin B subunit in the treatment of active Crohn's disease
P. Stal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Surface area assessment of the murine intestinal tract as a prerequisite for oral dose translation from mouse to man
C. Casteleyn et al.
LABORATORY ANIMALS (2010)
Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions
Margie Lee Clapper et al.
ACTA PHARMACOLOGICA SINICA (2007)
Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies
C Petterino et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2006)
Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease
M Stanford et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Share Paper
